Iproniazid (Marsilid) reverses dopamine-effect and stimulates the growth of mouse neuroblastoma in vitro.
D000818:Animals; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology; D018492:Dopamine Antagonists; D007490:Iproniazid / Q000494:pharmacology*; D051379:Mice; D008995:Monoamine Oxidase / Q000378:metabolism; D009447:Neuroblastoma; D013268:Stimulation, Chemical
D018492:Dopamine Antagonists; D007490:Iproniazid; D008995:Monoamine Oxidase; D004298:Dopamine